---
layout: post
title: USAN Watch - February 2012
date: '2012-02-14T17:16:00.001Z'
author: John Overington
tags:
- INNS and USANS
modified_time: '2012-02-14T18:22:27.235Z'
thumbnail: http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-6348151249547025953
blogger_orig_url: http://chembl.blogspot.com/2012/02/usan-watch-february-2012.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png"><img border="0" src="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png" /></a></div>
The USANs for February 2012 have just been published.<br />
<br />
<table border="1"><tbody>
<tr><td><b>USAN </b></td><td><b>Research Code </b></td><td><b>Structure</b></td><td><b>Drug Class</b></td><td><b>Therapeutic class</b></td><td><b>Target</b></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/aladorian.pdf">aladorian</a>, <a href="http://www.ama-assn.org/resources/doc/usan/aladorian-sodium.pdf">aladorian sodium</a></td><td><span class="Apple-style-span" style="font-family: inherit;">S44121-1, ARM-036, S36 &nbsp; &nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-SJ8cZYfv5RY/TzqU3FHJIxI/AAAAAAAABh4/LcZYUvqw7-I/s1600/aladorian.png"><img border="0" src="http://3.bp.blogspot.com/-SJ8cZYfv5RY/TzqU3FHJIxI/AAAAAAAABh4/LcZYUvqw7-I/s1600/aladorian.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>RyR</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/avatrombopag.pdf">avatrombopag</a>, <a href="http://www.ama-assn.org/resources/doc/usan/avatrombopag-maleate.pdf">avatrombopag maleate</a></td><td>E-5501, AKR-501</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-Wa4lCvXRWiM/TzqU9sLGyPI/AAAAAAAABiA/ULlKRYpSHPI/s1600/avatrombopag.png"><img border="0" src="http://2.bp.blogspot.com/-Wa4lCvXRWiM/TzqU9sLGyPI/AAAAAAAABiA/ULlKRYpSHPI/s1600/avatrombopag.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>TPOR</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/balugrastim.pdf">balugrastim</a></td><td>CG-10639</td><td></td><td>protein</td><td>therapeutic</td><td>GCSFR</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/baricitinib.pdf">baricitinib</a></td><td><span class="Apple-style-span" style="font-family: inherit;">LY-3009104, INCB-028050 &nbsp; &nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-ctd5jeM_5NA/TzqVE_vTsSI/AAAAAAAABiI/Te1J5B6pgfI/s1600/baricitinib.png"><img border="0" src="http://3.bp.blogspot.com/-ctd5jeM_5NA/TzqVE_vTsSI/AAAAAAAABiI/Te1J5B6pgfI/s1600/baricitinib.png" style="cursor: move;" /></a></span></td><td><span class="Apple-style-span" style="font-family: inherit;">synthetic small molecule</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">JAK1 JAK2</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/blisibimod.pdf"><span class="Apple-style-span" style="font-family: inherit;">blisibimod</span></a></td><td><span class="Apple-style-span" style="font-family: inherit;">A-623</span></td><td></td><td><span class="Apple-style-span" style="font-family: inherit;">protein</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">BAFF-R</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/brexpiprazole.pdf"><span class="Apple-style-span" style="font-family: inherit;">brexipiprazole</span></a></td><td><span class="Apple-style-span" style="font-family: inherit;">OPC-34712 &nbsp;&nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://1.bp.blogspot.com/-lkptGKVuL4Y/TzqVKu1CNMI/AAAAAAAABiQ/5m6QYihK4fk/s1600/brexpiprazole.png"><img border="0" src="http://1.bp.blogspot.com/-lkptGKVuL4Y/TzqVKu1CNMI/AAAAAAAABiQ/5m6QYihK4fk/s1600/brexpiprazole.png" style="cursor: move;" /></a></span></td><td><span class="Apple-style-span" style="font-family: inherit;">synthetic small molecule</span></td><td><span class="Apple-style-span" style="font-family: inherit;">therapeutic</span></td><td><span class="Apple-style-span" style="font-family: inherit;">D2R</span></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/clazakizumab.pdf"><span class="Apple-style-span" style="font-family: inherit;">clazakizumab</span></a></td><td><span class="Apple-style-span" style="font-family: inherit;">BMS-945429, ALD-518 </span><span style="font-family: ArialMT;">&nbsp; &nbsp;</span></td><td></td><td>mab</td><td>therapeutic</td><td>IL-6</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/enobosarm.pdf">enobosarm</a></td><td>GTx-024</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-ZWkKwfdyvrI/TzqVQuvIWfI/AAAAAAAABiY/FLJIoPEn2R4/s1600/enobosarm.png"><img border="0" src="http://2.bp.blogspot.com/-ZWkKwfdyvrI/TzqVQuvIWfI/AAAAAAAABiY/FLJIoPEn2R4/s1600/enobosarm.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>AR</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/ertugliflozin.pdf">ertugliflozin</a></td><td><span class="Apple-style-span" style="font-family: inherit;">PF-04971729-00&nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-V1iBmmoWk5o/TzqVY_hE2NI/AAAAAAAABig/YmlInMc3IhQ/s1600/ertugliflozin.png"><img border="0" src="http://4.bp.blogspot.com/-V1iBmmoWk5o/TzqVY_hE2NI/AAAAAAAABig/YmlInMc3IhQ/s1600/ertugliflozin.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>SGLT2</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/firtecan-pegol.pdf">firtecan pegol</a></td><td>EZN-2208</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-OzlFFxkBzgc/TzqVew5TjXI/AAAAAAAABio/Lq9mF-N9Oi8/s1600/firtecan.png"><img border="0" src="http://3.bp.blogspot.com/-OzlFFxkBzgc/TzqVew5TjXI/AAAAAAAABio/Lq9mF-N9Oi8/s1600/firtecan.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule conjugate prodrug</td><td>therapeutic</td><td>topo 1</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/giminabant.pdf">giminabant</a></td><td></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-Y7C3jl4U8WI/TzqVl5V6EBI/AAAAAAAABiw/yV1imL8Dxfg/s1600/giminabant.png"><img border="0" src="http://4.bp.blogspot.com/-Y7C3jl4U8WI/TzqVl5V6EBI/AAAAAAAABiw/yV1imL8Dxfg/s1600/giminabant.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>CB2</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/ibrutinib.pdf">ibrutinib</a></td><td><span class="Apple-style-span" style="font-family: inherit;">PCI-32765, CRA-032765, PCI-32765-00 &nbsp; &nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-BRoeLCQYel4/TzqWuikB6-I/AAAAAAAABjo/5WV3IE1sftc/s1600/ibrutinib.png"><img border="0" src="http://2.bp.blogspot.com/-BRoeLCQYel4/TzqWuikB6-I/AAAAAAAABjo/5WV3IE1sftc/s1600/ibrutinib.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>BTK</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/lipegfilgrastim.pdf">lipefilgrastim</a></td><td>XM-22</td><td></td><td>protein</td><td>therapeutic</td><td>GCSFR</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/momelotinib.pdf">momelotinib</a></td><td>CYT-387</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-xXT54PsPdic/TzqVr98kFDI/AAAAAAAABi4/lgDAYSvl4oQ/s1600/momelitinib.png"><img border="0" src="http://2.bp.blogspot.com/-xXT54PsPdic/TzqVr98kFDI/AAAAAAAABi4/lgDAYSvl4oQ/s1600/momelitinib.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>JAK1 JAK2</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/omarigliptin.pdf">omarigliptin</a></td><td>MK-3102 (?)</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-Ham4KDbPLrA/TzqVzUiepwI/AAAAAAAABjA/F11XB-G6gBU/s1600/omarigliptin.png"><img border="0" src="http://2.bp.blogspot.com/-Ham4KDbPLrA/TzqVzUiepwI/AAAAAAAABjA/F11XB-G6gBU/s1600/omarigliptin.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>DPP-IV</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/oprozomib.pdf">oprozomib</a></td><td>ONX-0912</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-woHre6H5jkw/TzqV6d8zhGI/AAAAAAAABjI/VFRaj4eDUlk/s1600/oprozomib.png"><img border="0" src="http://2.bp.blogspot.com/-woHre6H5jkw/TzqV6d8zhGI/AAAAAAAABjI/VFRaj4eDUlk/s1600/oprozomib.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>proteasome</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/nivolumab.pdf">nivolumab</a></td><td>MDX-1106, BMS-936558</td><td></td><td>mab</td><td>therapeutic</td><td>DR1</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/placulumab.pdf">placulumab</a></td><td><span class="Apple-style-span" style="font-family: inherit;">CEP-37247, ART-621, PN-0621 </span><span style="font-family: ArialMT;">&nbsp; &nbsp;</span></td><td></td><td>mab</td><td>therapeutic</td><td>TNFa</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/quisinostat.pdf">quisinostat</a></td><td><span class="Apple-style-span" style="font-family: inherit;">JNJ-26481585</span><span style="font-family: ArialMT;"> &nbsp;&nbsp;</span></td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-7J6wnDOkCb4/TzqWCK4UF0I/AAAAAAAABjQ/6Ja7bqjlTx8/s1600/quisinostat.png"><img border="0" src="http://4.bp.blogspot.com/-7J6wnDOkCb4/TzqWCK4UF0I/AAAAAAAABjQ/6Ja7bqjlTx8/s1600/quisinostat.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>HDAC</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/saridegib.pdf">saridegib</a>, <a href="http://www.ama-assn.org/resources/doc/usan/saridegib-hydrochloride.pdf">saridegib hydrochloride</a></td><td>IPI-926, FIN-5</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-2NtWzYQ0AaM/TzqWIPgwCJI/AAAAAAAABjY/H79Nzm1yc0Q/s1600/saridegib.png"><img border="0" src="http://4.bp.blogspot.com/-2NtWzYQ0AaM/TzqWIPgwCJI/AAAAAAAABjY/H79Nzm1yc0Q/s1600/saridegib.png" style="cursor: move;" /></a></span></td><td>natural product-derived small molecule</td><td>therapeutic</td><td>smoothened</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/technetium-tc-99m-etarfolatide.pdf">technetium Tc 99m etarfolatide</a></td><td>EC-20</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://1.bp.blogspot.com/-TU_25Eistdc/TzqWOPANN0I/AAAAAAAABjg/g7-6bMqRVZM/s1600/technetium.png"><img border="0" src="http://1.bp.blogspot.com/-TU_25Eistdc/TzqWOPANN0I/AAAAAAAABjg/g7-6bMqRVZM/s1600/technetium.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>imaging agent</td><td>Folate receptor</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/vocimagene-amiretrorepvec.pdf">vocimagene amiretrorepvec</a></td><td>TOCA-511</td><td></td><td>viral vector</td><td>therapeutic</td><td></td></tr>
</tbody></table>
<br /><div>
If anyone can confirm the MK- number for omarigliptin, or knows the MK- number for giminabant that would be great, as would the sequences for clazakizumab, nivolumab, placulumab.</div>